The institute is participating in NIAID tests of Moderna and Johnson & Johnson vaccines.
The investigational mRNA vaccine is also well tolerated, according to trial led by Kaiser Permanente Washington researcher and others.
Can lessons from Immunity Community help build acceptance of COVID-19 vaccines? Clarissa Hsu, PhD, thinks so.
KPWHRI’s Michael L. Jackson, PhD, MPH, talks about influenza vaccine research in the age of the pandemic.
National Institute of Allergy and Infectious Diseases-sponsored phase 1 trial tested mRNA vaccine.
Dr. Mike Jackson has long studied the spread of flu and effectiveness of vaccination at Kaiser Permanente Washington. And now… of COVID-19 too.
Led by Dr. Lisa A. Jackson, first-ever trial of any experimental vaccine candidate for COVID-19 virus has expanded.
Our Seattle offices sit on the occupied land of the Duwamish and by the shared waters of the Coast Salish people, who have been here thousands of years and remain. Learn about practicing land acknowledgment.